Thermogenesis Holdings Inc THMO shares are trading higher on Thursday.
TThermogenesis reported that, following submission to the FDA, the company received an acknowledgment letter which provided confirmation that the ThermoGenesis' SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit has been appropriately validated.
Thermogenesis shares were trading up 47.28% at $6.76 on Thursday. The stock has a 52-week high of $8.78 and a 52-week low of $1.63.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.